CA 242 is a new tumor marker for pancreatic cancer
- 1 February 1993
- Vol. 71 (3) , 701-707
- https://doi.org/10.1002/1097-0142(19930201)71:3<701::aid-cncr2820710308>3.0.co;2-c
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Comparison of serological expression of different epitopes on the CA50-carrying antigen CanAgInternational Journal of Cancer, 1991
- Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9British Journal of Cancer, 1989
- CA 19-9 and CA 50 in Benign and malignant pancreatic and biliary diseasesCancer, 1988
- Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system.Gut, 1987
- Serum CA 19-9 concentrations and computed tomography findings in patients with pancreatic carcinomaCancer, 1986
- Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitisBritish Journal of Cancer, 1986
- CA 19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitisEuropean Journal of Cancer and Clinical Oncology, 1985
- Diagnostische Bedeutung des Tumormarkers CA 19-9 beim PankreaskarzinomDeutsche Medizinische Wochenschrift (1946), 1984
- Colorectal carcinoma antigens detected by hybridoma antibodiesSomatic Cell and Molecular Genetics, 1979
- Predictive Value of a Single Diagnostic Test in Unselected PopulationsNew England Journal of Medicine, 1966